EMA Developing Strategy To Support Pharmacovigilance Assessments With Best Evidence
This article was originally published in SRA
Executive Summary
The European Medicines Agency and its pharmacovigilance committee, the PRAC, are conducting a pilot study that will help develop a strategy for supporting use of best evidence in regulatory decisions.